| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 204 | 2013 |
| European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe L Nacul, FJ Authier, C Scheibenbogen, L Lorusso, IB Helland, JA Martin, ... Medicina 57 (5), 510, 2021 | 136 | 2021 |
| Risk of relapse phenotype recurrence in multiple sclerosis T Kalincik, K Buzzard, V Jokubaitis, M Trojano, P Duquette, G Izquierdo, ... Multiple Sclerosis Journal 20 (11), 1511-1522, 2014 | 106 | 2014 |
| International consensus on quality standards for brain health-focused care in multiple sclerosis J Hobart, A Bowen, G Pepper, H Crofts, L Eberhard, T Berger, A Boyko, ... Multiple Sclerosis Journal 25 (13), 1809-1818, 2019 | 78 | 2019 |
| Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, ... Neurology 96 (5), e783-e797, 2021 | 75 | 2021 |
| Data quality evaluation for observational multiple sclerosis registries T Kalincik, J Kuhle, E Pucci, JI Rojas, M Tsolaki, CA Sirbu, M Slee, ... Multiple Sclerosis Journal 23 (5), 647-655, 2017 | 75 | 2017 |
| Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome C Meyniel, T Spelman, VG Jokubaitis, M Trojano, G Izquierdo, ... PloS one 7 (6), e38661, 2012 | 47 | 2012 |
| Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis T Kalincik, T Spelman, M Trojano, P Duquette, G Izquierdo, P Grammond, ... PloS one 8 (5), e63480, 2013 | 34 | 2013 |
| Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs S Stanciu, E Rusu, D Miricescu, AC Radu, B Axinia, AM Vrabie, R Ionescu, ... Metabolites 13 (1), 87, 2023 | 28 | 2023 |
| Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) M Aoun Sebaiti, M Hainselin, Y Gounden, CA Sirbu, S Sekulic, L Lorusso, ... Scientific reports 12 (1), 2157, 2022 | 26 | 2022 |
| Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union EB Strand, L Nacul, AM Mengshoel, IB Helland, P Grabowski, A Krumina, ... PloS one 14 (12), e0225995, 2019 | 22 | 2019 |
| Spinal intramedullary epidermoid cyst: case report and updated literature review OM Sîrbu, AV Chirteş, M Mitricã, CA Sîrbu World Neurosurgery 139, 39-50, 2020 | 19 | 2020 |
| Predictive factors in early onset schizophrenia M Budisteanu, E Andrei, F Linca, DS Hulea, AC Velicu, I Mihailescu, ... Experimental and therapeutic medicine 20 (6), 1-1, 2020 | 18 | 2020 |
| Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice CA Sirbu, RM Mezei, C Falup‑Pecurariu, OG Bratu, AM Sirbu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 17 | 2020 |
| Vaccination in multiple sclerosis‑Challenging practices CA Sirbu, AA Florea, MC Ghinescu, A Docu‑Axelerad, AM Sirbu, OG Bratu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 16 | 2020 |
| Docu Axelerad A, Ghinescu MC. Active pulmonary tuberculosis triggered by interferon beta-1b therapy of multiple sclerosis: four case reports and a literature review CA Sirbu, E Dantes, CF Plesa Medicina 56 (202), 10.3390, 2020 | 15 | 2020 |
| History of interferon treatments in multiple sclerosis-60 years of progress CA Sirbu, CM Dragoi, AC Nicolae, CF Plesa Farmacia 65 (1), 14-18, 2017 | 15 | 2017 |
| Influence of anti‑TNF therapy and homocysteine level on carotid intima‑media thickness in rheumatoid arthritis patients D Anghel, CA Sîrbu, EM Hoinoiu, OG Petrache, CF Pleșa, MM Negru, ... Experimental and Therapeutic Medicine 23 (1), 1-7, 2022 | 14 | 2022 |
| In vitro P-GP expression after administration of CNS active drugs AC Nicolae, AL Arsene, V Vuță, DE Popa, CA Sirbu, ... Farmácia 64 (6), 844-850, 2016 | 14 | 2016 |
| Pharmacological treatment of relapsing remitting multiple sclerosis-where are we CA Sirbu, E Furdu-Lungut, CF Plesa, AC Nicolae, CM Drăgoi Farmacia 64 (5), 651-655, 2016 | 14 | 2016 |
